본문 바로가기

Therapeutic implications of microRNAs in pulmonary arterial hypertension

문서 유형
연구출판물 · 리뷰논문
등재
KCISCIEScopus
저널 순위
JCR Q3Scopus Q3
저널
BMB Reports47(6) · pp.311 · 2014
피인용
Web of Science 34KCI 4
JCR IF
JCR 2013 1.988
ISSN
1976-6696

저자

  1. 이아람숙명여자대학교
  2. Danielle McLeanUniversity of Vermont
  3. 최지혜숙명여자대학교
  4. 강혜수숙명여자대학교
  5. 장우철부산대학교
  6. 김종민교신저자숙명여자대학교

초록

microRNAs (miRNAs) are a class of small, non-coding RNAs that play critical posttranscriptional regulatory roles typically through targeting of the 3'-untranslated region of messenger RNA (mRNA). Mature miRNAs are known to be involved in global cellular processes, such as differentiation, proliferation, apoptosis, and organogenesis, due to their capacity to target multiple mRNAs. Thus, imbalances in the expression and/or activity of miRNAs are involved in the pathogenesis of numerous diseases, including pulmonary arterial hypertension (PAH). PAH is a progressive disease characterized by vascular remodeling due to excessive proliferation of pulmonary artery endothelial cells (PAECs) and pulmonary artery smooth muscle cells (PASMCs). Recently, studies have evaluated the roles of miRNAs involved in the pathogenesis of PAH in these pulmonary vascular cells. This review provides an overview of recent discoveries on the role of miRNAs in the pathogenesis of PAH and discusses the potential for miRNAs as therapeutic targets and biomarkers of PAH.

키워드

BiomarkermicroRNAPulmonary arterial hypertensionPulmonary vascular cellSignaling pathwaySMOOTH-MUSCLE-CELLSBONE MORPHOGENETIC PROTEINCHRONIC HYPOXIARECEPTORINHIBITIONEXPRESSIONRNASPROLIFERATIONBIOGENESISPROMOTES

식별자

WoS UID
000338696400002
KCI
ART001883449